RxDoctor Payments DataLook up a doctor →

Neal Shore

Urology · Myrtle Beach, SCNPI 1265423453

Payments from drug & device makers

$63,322,967in general payments, 2019–2025

Across 5,540 payments — averaging $11,430 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$17.4M
  • Merck$14.6M
  • Bayer$12.6M
  • Janssen Research & Development, LLC$5M
  • Medivation LLC.$2.3M
  • AstraZeneca$2.2M
  • plus $9.2M from 54 others
$283,154in research payments, 2019–2025

Across 408 payments — averaging $694.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$187K
  • Astellas Pharma Global Development$52K
  • Novartis$40K
  • Novartis Pharma AG$4K
  • Eli Lilly$73

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer823$17,427,189
Merck645$14,610,531
Bayer991$12,596,928
Janssen Research & Development, LLC665$5,007,466
Medivation LLC.276$2,322,468
AstraZeneca129$2,184,090
Astrazeneca UK Limited65$1,543,984
Exelixis Inc.185$1,106,857
Novartis76$789,861
E.r. Squibb & Sons, L.L.C.63$689,714
Astellas Pharma Global Development92$658,335
Genentech, Inc.55$457,680
SN Holdings, LLC55$442,496
Seagen Inc.73$437,796
Macrogenics, Inc.46$378,409
Dendreon Pharmaceuticals LLC133$270,265
Ortho-clinical Diagnostics, Inc.18$258,841
Photocure Inc28$237,261
Astrazeneca AB4$215,194
Veru Inc.23$176,088
Sumitomo Pharma America, Inc.57$158,995
Sanofi64$128,721
Urogen Pharma, Inc.141$126,871
Eli Lilly14$96,305
Ferring Pharmaceuticals Inc.51$86,386
Palette Life Sciences, Inc.10$75,418
Myovant Sciences Inc.34$69,779
Janssen Scientific Affairs, LLC17$66,133
Boston Scientific39$59,753
Janssen Global Services, LLC45$58,506
Astellas Pharma US Inc58$57,532
Johnson & Johnson(2 entities)77$49,756
Amgen27$47,071
Siemens Medical Solutions USA, Inc.13$41,905
Ferring Pharmaceuticals AS12$39,028
Clovis Oncology, Inc.26$29,747
Ferring International Center SA17$29,681
Advanced Accelerator Applications8$27,219
Tolmar Pharmaceuticals, Inc.9$17,924
Foundation Medicine, Inc.17$17,886
Bristol Myers Squibb1$17,800
Laborie Medical Technologies Corp.28$17,696
OPKO Pharmaceuticals, LLC5$16,766
Progenics Pharmaceuticals, Inc.24$16,401
Teleflex LLC8$15,797
Tolmar, Inc.6$15,091
Blue Earth Diagnostics23$12,600
Integra GPO, LLC7$11,413
AbbVie(2 entities)23$11,272
Daiichi Sankyo Inc.11$9,507
Illumina, Inc.9$9,178
Incyte Corporation23$8,906
Telix Pharmaceuticals7$8,434
Myriad Genetic Laboratories, Inc.20$6,801
GSK5$6,500
Nonagen Bioscience Corp1$5,688
Novartis Pharma AG1$4,950
Neotract Inc.1$4,450
Ferring Pharmaceuticals Private Limited1$4,175
Orion Corporation1$3,701

How this compares

$63,322,967 in reported general payments places this provider in the 95th percentile of 196 urology providers in South Carolina.

See all urology providers in South Carolina →

Medicare billing

Part B allowed, 2024
$1,232,493
Medicare patients
962
Services billed
27,418

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Myrtle Beach

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →